Arbutus Biopharma
ABUS
#6407
Rank
HK$4.72 B
Marketcap
HK$24.94
Share price
0.00%
Change (1 day)
34.74%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2024 (TTM): -HK$0.6 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are HK$6.74 Million. In 2023 the company made an earning of -HK$0.57 Billion a decrease over its 2022 earnings that were of -HK$0.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.6 Billion5.76%
2023 -HK$0.57 Billion12.05%
2022 -HK$0.51 Billion-14.74%
2021 -HK$0.6 Billion19.61%
2020 -HK$0.5 Billion-61.69%
2019 -HK$1.3 Billion171.23%
2018 -HK$0.48 Billion-43.58%
2017 -HK$0.85 Billion-77.77%
2016 -HK$3.81 Billion532.77%
2015 -HK$0.61 Billion99.05%
2014 -HK$0.31 Billion175.82%
2013 -HK$0.11 Billion-143.7%
2012 HK$0.25 B-399.11%
2011 -HK$83.71 Million-39.03%
2010 -HK$0.14 Billion100.55%
2009 -HK$68.45 Million-28.56%
2008 -HK$95.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$0.29 B-148.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$16.79 Million-97.18% Bahamas